Invention Grant
- Patent Title: Quinoline compounds as IRAK inhibitors and uses thereof
-
Application No.: US16966285Application Date: 2019-01-15
-
Publication No.: US11542246B2Publication Date: 2023-01-03
- Inventor: Catherine Jorand-Lebrun , Roch Boivin
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: EMD Serono Research and Development Institute, Inc.
- Agent Nicholas J. Sisti
- International Application: PCT/EP2019/050985 WO 20190115
- International Announcement: WO2019/149522 WO 20190808
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D471/04
Abstract:
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
Public/Granted literature
- US20200369646A1 QUINOLINE COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF Public/Granted day:2020-11-26
Information query
